Automating Medicare Part D Peer-to-Peer Scheduling
Klivira's platform automates Medicare Part D peer-to-peer scheduling, transforming a high-friction workflow into an efficient process for resolving medication prior authorization denials. This ensures timely access to prescribed therapies under Part D benefits.
For revenue cycle directors, prior authorization coordinators, and IT integration leads, managing peer-to-peer (P2P) reviews for Medicare Part D medications presents unique challenges. Denials often stem from clinical necessity disputes related to drug formularies or off-label indications, requiring swift resolution to prevent care delays. Klivira provides a structured, automated approach to P2P scheduling, specifically designed to navigate the complexities of Part D benefit administration.
The Challenge of Medicare Part D P2P Scheduling
Medicare Part D prior authorizations are frequently managed by Pharmacy Benefit Managers (PBMs) and involve drug-specific criteria. When a denial occurs due to clinical necessity, initiating a peer-to-peer review manually can be a significant bottleneck. Coordinators must reconcile clinician availability with PBM medical director schedules, often under tight deadlines, to discuss medication efficacy, alternatives, and formulary adherence.
Common Hurdles in Manual Part D P2P Workflows
- **PBM-Specific Scheduling Interfaces:** Navigating diverse PBM portals or contact methods to request and schedule P2P calls.
- **Clinician Calendar Bottleneck:** Reconciling the ordering clinician's calendar, often booked weeks in advance, with limited PBM medical director availability.
- **Missed P2P Windows:** Short deadlines for PBM-offered P2P slots can lead to missed opportunities, forcing more formal, lengthy appeals.
- **Pre-Call Documentation Gaps:** Assembling comprehensive clinical documentation, prior-line therapies, and peer-reviewed literature for specific medications can be time-consuming.
- **Inconsistent Outcome Capture:** Manual tracking of P2P outcomes (approval, modification, upheld denial) for Part D medications can lead to data inconsistencies and delayed EMR updates.
Klivira's Automated Approach to Part D Peer-to-Peer Scheduling
Klivira's platform integrates seamlessly into your existing EMR and payer connectivity, automating critical steps in the Medicare Part D peer-to-peer scheduling process. Our denial-router intelligently identifies P2P-eligible medication denials, initiating an automated workflow that minimizes manual intervention and clinician burden. This ensures that clinical necessity disputes for Part D drugs are addressed promptly and efficiently.
Key Automation Features for Part D P2P Reviews
- **Auto-Detection of P2P-Eligible Denials:** Klivira's system identifies Part D medication denials requiring P2P based on clinical necessity or formulary exceptions.
- **PBM Availability Discovery:** Automated ingestion of PBM medical director availability or initiation of requests via ePA channels like NCPDP SCRIPT for scheduling.
- **Clinician-Calendar Integration:** Direct integration with ordering clinicians' calendars via FHIR Appointment resources or common calendar systems (e.g., Outlook, Google Calendar) to find optimal mutual availability.
- **Automated Pre-Call Packet Assembly:** FHIR-based documentation discovery pulls relevant clinical notes, lab results, prior-line therapies, and drug-specific literature into a structured packet for the clinician.
- **Outcome Capture & EMR Write-back:** Structured post-call forms capture P2P outcomes, routing them as FHIR DocumentReference and Communication writes to the EMR and triggering downstream workflows.
Ensuring Compliance and Efficiency in Part D P2P Reviews
Adherence to Medicare Part D regulations and efficient handling of Protected Health Information (PHI) are paramount during P2P reviews. Klivira's platform is designed to support these requirements by providing auditable workflows and secure data exchange. By automating scheduling and documentation, we help ensure that P2P processes for Part D medications are not only efficient but also compliant with relevant standards, including those for ePHI.
Driving Better Outcomes with Part D P2P Analytics
Beyond scheduling, Klivira provides P2P pattern analytics specific to Medicare Part D denials. By analyzing success rates based on denial reason, PBM, and specific medications, your organization can gain insights to inform upstream prior authorization submissions. This feedback loop helps improve initial PA accuracy for Part D drugs, ultimately reducing the overall volume of denials requiring P2P intervention.
Frequently asked questions
How does Klivira handle PBM-specific requirements for Medicare Part D P2P scheduling?
Klivira's platform is designed to integrate with various payer and PBM systems. For Medicare Part D, we can ingest PBM-published P2P availability schedules or initiate requests via established channels, including those supporting ePA standards like NCPDP SCRIPT, to secure call windows. Our system adapts to the specific contact mechanisms provided by each PBM.
Can Klivira integrate with our EMR to pull medication-specific clinical documentation for Part D P2P calls?
Yes, Klivira leverages FHIR-based documentation discovery to pull relevant clinical notes, prior-line therapy history, lab/imaging results, and even peer-reviewed literature for off-label medication cases directly from your EMR. This ensures the ordering clinician has a comprehensive, pre-assembled packet tailored to the specific Medicare Part D drug denial before the P2P call.
How does Klivira help reduce clinician burden related to Medicare Part D P2P reviews?
Klivira significantly reduces clinician burden by automating the most time-consuming aspects of P2P. This includes identifying eligible denials, reconciling calendars, scheduling calls, assembling documentation packets, and sending reminders. While the clinician still participates in the P2P call, the administrative overhead is drastically minimized, freeing up valuable clinical time.
What happens after a Medicare Part D P2P call with Klivira's system?
Post-call, Klivira provides a structured form for clinicians to capture the P2P outcome (e.g., approval, modification, upheld denial). This outcome is then automatically routed into your EMR as FHIR DocumentReference and Communication writes. The system can also trigger downstream workflows, such as approval write-back, appeal escalation, or scheduling for revised medication orders.
Does Klivira provide analytics on Medicare Part D P2P success rates?
Yes, Klivira collects and analyzes P2P outcome data, providing insights into success patterns by denial reason, specific PBMs, and individual clinicians. This intelligence helps inform and refine your upstream prior authorization submission processes for Medicare Part D medications, aiming to reduce future denials and the need for P2P interventions.
Related coverage
Ready to automate prior auth for this line of business?
See how Klivira automates prior authorizations for your team.
Request a demo